Loading
WHO's list of the vaccines it has prequalified, one row per presentation, with the maker and the regulator responsible for each.
The export read on 4 November 2026 has 287 presentation rows. For cancer prevention it lists six HPV vaccines (Gardasil, Gardasil 9, Cervarix, Cecolin, Walrinvax and CERVAVAC, the last prequalified on 25 September 2026) and five monovalent hepatitis B vaccines (Engerix, Euvax B, BEVAC, Heberbiovac HB and the Serum Institute of India's Hepatitis B Vaccine (rDNA)), as well as childhood combination vaccines that contain hepatitis B.
Shares BEVAC hepatitis B vaccine (Biological E), Heberbiovac HB (hepatitis B vaccine, Cuba), Euvax B (hepatitis B vaccine, LG Chem), Hepatitis B Vaccine (rDNA), Serum Institute of India.
Shares BEVAC hepatitis B vaccine (Biological E), Heberbiovac HB (hepatitis B vaccine, Cuba), Euvax B (hepatitis B vaccine, LG Chem), Hepatitis B Vaccine (rDNA), Serum Institute of India.
Shares Cecolin (bivalent HPV vaccine, Xiamen Innovax), Nonavalent HPV vaccine.
Shares Hepatitis B Vaccine (rDNA), Serum Institute of India, CERVAVAC (quadrivalent HPV vaccine, India).
Shares HPV bivalent vaccine (types 16 and 18), Nonavalent HPV vaccine.
Shares CERVAVAC (quadrivalent HPV vaccine, India), Nonavalent HPV vaccine.
Shares CERVAVAC (quadrivalent HPV vaccine, India), Nonavalent HPV vaccine.
Shares CERVAVAC (quadrivalent HPV vaccine, India), Nonavalent HPV vaccine.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/